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Endothelium is the endocrine organ essential for mainte-
nance of homeostasis in the entire body. Healthy endothelial
cells regulate antioxidants, have anti-inﬂammatory and anti-
coagulant action, and, thus, control vascular relaxation and
contraction, thrombogenesis, ﬁbrinolysis, and platelet activa-
tion and inhibition. Maintaining the functional integrity of
this complex organ is, therefore, critical for preserving blood
ﬂow and preventing thrombosis.
Endothelium dysfunction (ED) may result in the loss of
important homeostatic functions, which, in turn, leads to
various pathologies. ED has been observed in relation to
ageing as well as inmajor lifestyle-related diseases, suggesting
that endothelium dysfunction can serve as a means of
identifying people for the purpose of preventing and treating
various diseases. For example, ED is the initial stage in
the pathogenesis of peripheral artery disease, cardiovascular
diseases, chronic venous disease, chronic kidney failure,
cancer, infectious diseases, and obesity.
is special issue comprises seven original research arti-
cles and two reviews, summarised in brief below, that delve
into the important research being conducted on endothelial
function.
e loss of endothelial integrity and function is a crit-
ical component of the onset of the adverse changes that
result in cardiovascular disease. Injury of the endothelium
is a consequence of haemodynamic (e.g., wall shear stress),
chemical (e.g., low-density lipoprotein (LDL) cholesterol or
glucose), or biologic factors (e.g., immune complexes). It is
a known fact that mechanical factors, such as shear stress,
are involved in the insult to the endothelial cells, but the
level of this ﬂuid drag force, which could damage the cells as
well as the way they work, is still being studied. In the paper
“Computing of Low Shear Stress-Driven Endothelial Gene
Network Involved in Early Stages of Atherosclerotic Process”,
F. Vozzi et al. study the impact of diﬀerent shear stress levels
on endothelial gene expression in vitro using a laminar ﬂow
bioreactor. e authors show that diﬀerent shear stress levels
have a signiﬁcant inﬂuence on the activity of the endothelial
cells and their metabolic proﬁle. ey also demonstrate that
lower shear stress promoted the proliferation properties of
the examined cells by ﬂow-induced gene expression modu-
lation of some endothelial genes (upregulation for the genes
particularly linked to the inﬂammation and apoptosis versus
downregulation for the contrary acting genes).
Likewise, loss of endothelial integrity permits lipid inﬁl-
tration, which forms the so lipid of the atheromatous plaque.
Many factors inﬂuence the development of atheromatous
plague, many of which (so-called “modiﬁable risk factors”)
can be successfully treated. Amongst the applicable thera-
pies are antiplatelet therapy and statin therapy. Both can
result in very simple improvements, such as a decrease in
platelet activity or a reduction in cholesterol level. However,
the inﬂammatory theory of atherosclerosis resulted in the
examination of these therapies’ potential anti-inﬂammatory
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eﬀects as the usefulness and eﬀectiveness of the drugs were
assessed. In their paper “Simvastatin Eﬀects on Inﬂammation
and Platelet Activation Markers in Hypercholesterolemia”, C.
Barale et al. conﬁrm that, in addition to its lipid-lowering
eﬀect, simvastatin acts as an anti-inﬂammatory and platelet-
inhibiting agent. In their study, the simvastatin also improved
the parameters of ED in patients with hypercholesterolemia.
ese changes were most likely a part of the pleiotropic eﬀect
attributed to the 3-hydroxy-3-methylglutaryl coenzyme A
(HMG-CoA) reductase inhibitors. e authors also suggest
that a high LDL cholesterol level, which can be controlled by
statins, could be responsible for platelet hyperactivity.
In their paper, P. A. Maranha˜o et al. demonstrate that
ingestion of a high-fat meal involves the impairment of
microvascular function in both obese and normal-weight
women. High-fat meal intake can acutely impair microvas-
cular function by inducing hyperinsulinemia, endothelial
activation, and inﬂammation. is mechanism worsened
ED in the obese women and induced the impairment of
endothelial function in the normal-weight women. Due to
the key role of ED in atherosclerosis, these ﬁndings may also
explain the association between ingestion of a high-fat meal
and atherosclerosis.
In their review paper, J. Gawrys et al. present the inter-
actions between the cyclooxygenase metabolic pathway and
the renin-angiotensin-aldosterone systems (RAAS) in the
context of endothelial function balance disturbance. Based
on available data, their brief review also summarises the data
regarding usefulness and safety of the Acetylsalicylic acid
(ASA) combination with drugs that act directly on RAAS.
In another review paper, M. Jakubowski et al. outline
the current knowledge regarding the role of human platelet
carbonic anhydrase II (CAII) in regulating platelet function.
e paper also describes the consideration of this enzyme as a
potential drug target and important pathophysiological chain
in platelet-related disorders.
e known result of hyperglycaemia is tissue dam-
age as a consequence of many mechanisms according to
the polyol pathway, production of advanced glycation end
products (AGEs), protein kinase C, and the hexosamine
pathway, which are responsible for overproduction of the
reactive oxygen species. Moreover, hyperglycaemia appears
to be the major determinant of the diabetic microvascular
complications’ retinopathy, neuropathy, and nephropathy.
Most signiﬁcantly, kidney disease in patients with diabetes
aggravates hypertension, which can further damage the
kidneys and leads to end-stage renal disease. Because there
is still no eﬀective treatment for this complication, early
diagnosis with treatment plays a crucial role in patient care.
Furthermore, factors or molecules that can be detected in
the early stages of nephropathy could lead to new oppor-
tunities for further treatment and may well also serve as
a marker of endothelial damage, with all of its cardiovas-
cular consequences. Such a factor appears to be the novel
proangiogenic factor leucine-rich-𝛼2-glycoprotein-1 (LRG1),
which promotes abnormal angiogenesis within the renal
glomerulus.
LRG1-induced abnormal angiogenesis resulting in
glomerular ﬁbrosis was observed in mice in a study by S.
Haku et al. and is presented in the paper “Early Enhanced
Leucine-Rich 𝛼-2-Glycoprotein-1 Expression in Glomerular
Endothelial Cells of Type 2 Diabetic Nephropathy Model
Mice”. Because the glomerular LRG1 expression was
increased before the vascular endothelial growth factor
(VEGF) and vascular endothelial growth factor receptor-2
(VEGFR-2) increased, the authors suggest that glomerular
LRG1 is an earlier marker of abnormal angiogenesis within
the renal glomerulus than the mentioned classical growth
factors.
For their part, M. A. Ortega et al. examined the behaviour
of smooth muscle cells (SMCs) under hypoxic conditions:
possible implications on the varicose vein endothelium.
e authors share that the muscle cells of people with
varicose veins showed levels of the studied markers (hypoxia-
inducible factors 1𝛼 (HIF-1𝛼), VEGF, transforming growth
factor-𝛽1 (TGF-𝛽1), and endothelial nitric oxide synthase
(eNOS) similar to normal cells subjected to hypoxia). ey
also demonstrate that, were the hypoxia to continue over
the longer term, these cells would no longer have the
capacity to react, and the factor that attempts to com-
pensate for the hypoxia (EGLN3) would fail. Additionally,
the authors presented totally diﬀerent status for healthy
subjects (controls) compared to the patients with venous
insuﬃciency according to the VEGF level change. Apart
from the diﬀerence in baseline VFGF concentration in
normoxic conditions (higher level in patients with venous
insuﬃciency), in the control group, the expression of VEGF
raised in response to long- term hypoxia while in patients
with varicose veins this factor’s level decreased signiﬁ-
cantly.
e role of bone marrow-derived endothelial progenitor
cells (EPCs) in monocrotaline-induced pulmonary arterial
hypertension (PAH) is demonstrated in an original paper by
R. Miao et al. In their study, it appeared that an increase in
cytosolic free Ca2+ is identiﬁed as a trigger for promoting
both proliferation and vasoconstriction of the pulmonary
arterial smoothmuscle cells.e balance of cytosolic calcium
is controlled by the store-operated Ca2+ channels (SOC) in
human EPCs, which is mediated by the Orai and the canon-
ical transient receptor potential channels. e results of the
study suggest that the association between the low expression
of the major mediators of SOC and Ca2+ homeostasis may
lead to PAH.
Endothelial function in children with acute lymphoblas-
tic leukaemia (ALL) may predict he clinical outcome. A.
Doroszko et al. demonstrate that high baseline vascular
endothelial growth factor (VEGF) and soluble E-selectin
levels, along with a signiﬁcant increase in plasminogen acti-
vator inhibitor-1 (PAI-1) and low initial soluble intercellular
adhesion molecule 1(sICAM-1) levels, are predictive of poor
prognosis in ALL children.
e editors of the special issue, which is dedicated to the
new insights to the endothelial function and its pathological
states, strongly believe that the knowledge contained in this
issue will mobilize many scientists to the further work as well
as contributing to a better understanding human’s physiology
and pathology.
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